Facebook may be split, and a US judge requires it to face government antitrust litigation

Beyond Capital: Why Europe Needs Industrial Partners, Not Just Investors

Europe’s reindustrialization is creating new opportunities for Chinese companies. However, the winners will not necessarily be those seeking quick acquisitions or rapid market access. The real opportunities belong to companies capable of embedding themselves into Europe’s industrial ecosystem and supporting the long-term transformation of local industries.

Precision Reducer Manufacturer Talls Intelligent Technology Secures CNY 140 Million in Financing

Talls Intelligent Technology（陶世智能）Raises CNY 140 Million, Secures Order for 100,000 Dexterous Hands

SEEV Raises Nearly CNY 200 Million in Two Funding Rounds, Targeting Mass-Production Window for Full-Color AR Waveguides

EO reported on August 5 that AR diffractive waveguide manufacturer SEEV（广纳四维）had completed two consecutive funding rounds, raising nearly CNY 200 million in total.

DeepSeek Restarts CNY 50 Billion Funding Round as V4-Flash Tops Global AI Usage Rankings

DeepSeek (深度求索) has reportedly restarted its second funding round, seeking CNY 50 billion at a pre-money valuation of around CNY 500 billion, as the Chinese AI company simultaneously strengthens its position in the global large-language-model market. The financing is expected to be signed in late August, according to Chinese financial media reports.

Alphamab Licenses Cancer Drug to Pathos AI in Deal Worth More Than US$2.2 Billion

Alphamab Oncology (康宁杰瑞生物制药) has licensed the overseas rights to its experimental cancer drug JSKN016 to US-based Pathos AI in a deal potentially worth more than US$2.2 billion, marking another major overseas licensing agreement for China’s rapidly expanding innovative-drug sector.